Olympus Corporation (OCPNF)
USD 15.5
(0.0%)
USD 15.5
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 212.3 Billion JPY | -117.76% |
| 2023 | 232.66 Billion JPY | 48.61% |
| 2022 | 156.56 Billion JPY | -36.97% |
| 2021 | 248.39 Billion JPY | 50.62% |
| 2020 | 164.91 Billion JPY | 117.16% |
| 2019 | 75.94 Billion JPY | 16.4% |
| 2018 | 65.24 Billion JPY | -32.0% |
| 2017 | 95.94 Billion JPY | -41.96% |
| 2016 | 165.28 Billion JPY | 14.35% |
| 2015 | 144.54 Billion JPY | -11.71% |
| 2014 | 163.71 Billion JPY | -50.51% |
| 2013 | 330.78 Billion JPY | -25.22% |
| 2012 | 442.33 Billion JPY | 1.63% |
| 2011 | 435.22 Billion JPY | -4.28% |
| 2010 | 454.69 Billion JPY | -13.12% |
| 2009 | 523.34 Billion JPY | 4.99% |
| 2008 | 498.47 Billion JPY | 92.29% |
| 2007 | 259.22 Billion JPY | -11.31% |
| 2006 | 292.29 Billion JPY | 11.72% |
| 2005 | 261.63 Billion JPY | 106.78% |
| 2004 | 126.52 Billion JPY | 26.99% |
| 2003 | 99.63 Billion JPY | -11.68% |
| 2002 | 112.8 Billion JPY | -13.47% |
| 2001 | 130.37 Billion JPY | 0.0% |
| 2000 | - JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -139.74 Billion JPY | 34.32% |
| 2024 Q1 | -212.75 Billion JPY | -191.44% |
| 2024 FY | 212.3 Billion JPY | -8.75% |
| 2024 Q4 | 212.3 Billion JPY | 583.69% |
| 2024 Q3 | -43.89 Billion JPY | 68.59% |
| 2023 Q2 | 134.03 Billion JPY | 23.67% |
| 2023 FY | 232.66 Billion JPY | 48.61% |
| 2023 Q4 | 232.66 Billion JPY | 31.46% |
| 2023 Q1 | 108.38 Billion JPY | -30.77% |
| 2023 Q3 | 176.98 Billion JPY | 32.05% |
| 2022 FY | 156.56 Billion JPY | -36.97% |
| 2022 Q1 | 166.35 Billion JPY | -35.83% |
| 2022 Q3 | 118.01 Billion JPY | -16.86% |
| 2022 Q2 | 141.93 Billion JPY | -14.68% |
| 2022 Q4 | 156.56 Billion JPY | 32.67% |
| 2021 Q2 | 197.11 Billion JPY | 57.17% |
| 2021 Q1 | 125.41 Billion JPY | 5.91% |
| 2021 FY | 248.39 Billion JPY | 50.62% |
| 2021 Q4 | 259.24 Billion JPY | 32.22% |
| 2021 Q3 | 196.07 Billion JPY | -0.53% |
| 2020 Q3 | 122.42 Billion JPY | -16.36% |
| 2020 Q1 | 68.28 Billion JPY | 2.06% |
| 2020 Q4 | 118.42 Billion JPY | -3.27% |
| 2020 Q2 | 146.37 Billion JPY | 114.35% |
| 2020 FY | 164.91 Billion JPY | 117.16% |
| 2019 Q4 | 66.9 Billion JPY | -16.93% |
| 2019 FY | 75.94 Billion JPY | 16.4% |
| 2019 Q2 | 74.57 Billion JPY | 23.72% |
| 2019 Q1 | 60.27 Billion JPY | 6.24% |
| 2019 Q3 | 80.54 Billion JPY | 8.0% |
| 2018 Q2 | 81.26 Billion JPY | -13.4% |
| 2018 Q1 | 93.84 Billion JPY | 8.48% |
| 2018 FY | 65.24 Billion JPY | -32.0% |
| 2018 Q4 | 56.73 Billion JPY | -25.45% |
| 2018 Q3 | 76.1 Billion JPY | -6.36% |
| 2017 Q3 | 140 Billion JPY | -11.86% |
| 2017 Q2 | 158.84 Billion JPY | 4.7% |
| 2017 Q1 | 151.71 Billion JPY | -1.43% |
| 2017 FY | 95.94 Billion JPY | -41.96% |
| 2017 Q4 | 86.5 Billion JPY | -38.21% |
| 2016 Q1 | 126.07 Billion JPY | -12.78% |
| 2016 Q4 | 153.92 Billion JPY | 46.01% |
| 2016 Q2 | 121.25 Billion JPY | -3.82% |
| 2016 FY | 165.28 Billion JPY | 14.35% |
| 2016 Q3 | 105.41 Billion JPY | -13.06% |
| 2015 Q1 | 153.03 Billion JPY | -6.52% |
| 2015 FY | 144.54 Billion JPY | -11.71% |
| 2015 Q2 | 151.25 Billion JPY | -1.16% |
| 2015 Q3 | 150.61 Billion JPY | -0.42% |
| 2015 Q4 | 144.54 Billion JPY | -4.03% |
| 2014 Q4 | 163.71 Billion JPY | -11.23% |
| 2014 FY | 163.71 Billion JPY | -50.51% |
| 2014 Q3 | 184.41 Billion JPY | -6.35% |
| 2014 Q2 | 196.92 Billion JPY | -39.27% |
| 2014 Q1 | 324.27 Billion JPY | -1.97% |
| 2013 Q2 | 395.48 Billion JPY | -8.76% |
| 2013 Q1 | 433.45 Billion JPY | -2.01% |
| 2013 FY | 330.78 Billion JPY | -25.22% |
| 2013 Q4 | 330.78 Billion JPY | -13.68% |
| 2013 Q3 | 383.19 Billion JPY | -3.11% |
| 2012 Q2 | 432.14 Billion JPY | -1.04% |
| 2012 Q3 | 435.33 Billion JPY | 0.74% |
| 2012 Q4 | 442.33 Billion JPY | 1.61% |
| 2012 FY | 442.33 Billion JPY | 1.63% |
| 2012 Q1 | 436.67 Billion JPY | 0.33% |
| 2011 FY | 435.22 Billion JPY | -4.28% |
| 2011 Q2 | 443.12 Billion JPY | -3.67% |
| 2011 Q3 | 463.71 Billion JPY | 4.64% |
| 2011 Q4 | 435.22 Billion JPY | -6.14% |
| 2011 Q1 | 459.99 Billion JPY | 1.16% |
| 2010 Q1 | 515.47 Billion JPY | -1.5% |
| 2010 FY | 454.69 Billion JPY | -13.12% |
| 2010 Q3 | 432.77 Billion JPY | -5.81% |
| 2010 Q4 | 454.69 Billion JPY | 5.07% |
| 2010 Q2 | 459.45 Billion JPY | -10.87% |
| 2009 Q3 | 522.26 Billion JPY | -2.21% |
| 2009 FY | 523.34 Billion JPY | 4.99% |
| 2009 Q2 | 534.09 Billion JPY | 0.0% |
| 2009 Q4 | 523.34 Billion JPY | 0.21% |
| 2008 FY | 498.47 Billion JPY | 92.29% |
| 2007 FY | 259.22 Billion JPY | -11.31% |
| 2006 FY | 292.29 Billion JPY | 11.72% |
| 2005 FY | 261.63 Billion JPY | 106.78% |
| 2004 FY | 126.52 Billion JPY | 26.99% |
| 2003 FY | 99.63 Billion JPY | -11.68% |
| 2002 FY | 112.8 Billion JPY | -13.47% |
| 2001 FY | 130.37 Billion JPY | 0.0% |
| 2000 FY | - JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -44264761.946% |
| Ansell Limited | -54.99 Million USD | 386136.507% |
| Ansell Limited | -55.1 Million USD | 385413.975% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 581874.681% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 202001964.855% |
| Psykey, Inc. | 634.59 Thousand USD | -33455674.016% |
| ConvaTec Group Plc | 1.2 Billion USD | -17583.457% |
| ConvaTec Group Plc | 1.2 Billion USD | -17558.488% |
| Encision Inc. | 1.29 Million USD | -16449047.861% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -9195830.034% |
| Innovative MedTech Inc. | 1.76 Million USD | -12030481.345% |
| LifePoint, Inc. | -3.26 Million USD | 6504592.465% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -4329021.554% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -9819881.499% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 490273515.851% |
| Reflect Scientific, Inc. | -1.03 Million USD | 20506867.558% |
| SmileDirectClub, Inc. | 778.67 Million USD | -27165.22% |
| Sector 10, Inc. | 163 Thousand USD | -130250206.748% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 50945.609% |
| SheerVision, Inc. | 57.34 Thousand USD | -370203390.907% |
| United Health Products, Inc. | 660.56 Thousand USD | -32140070.066% |
| Vasamed, Inc. | 22.12 Thousand USD | -959714211.545% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -8068707.652% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -27491001.014% |